- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: H.129, V.132, E.134, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 6 residues within 4Å:- Chain A: D.313, N.342, T.345, N.594, L.597
- Chain C: Y.515
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 2 residues within 4Å:- Chain A: V.651, N.653
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain A: H.671, N.673, Y.734
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain A: D.606, N.691, N.692
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.606
NAG-NAG.7: 4 residues within 4Å:- Chain A: D.702, N.713, T.715, D.716
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 3 residues within 4Å:- Chain B: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.11
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 1 residues within 4Å:- Chain B: N.16
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain B: H.129, V.132, E.134, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 9 residues within 4Å:- Chain A: Y.515, D.516, P.517, R.518
- Chain B: D.313, N.340, N.342, N.594, L.597
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.597
NAG-NAG.14: 2 residues within 4Å:- Chain B: V.651, N.653
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 4 residues within 4Å:- Chain B: D.606, V.607, N.691, N.692
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 4 residues within 4Å:- Chain B: D.702, N.713, T.715, D.716
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 6 residues within 4Å:- Chain B: V.1201, N.1202
- Chain C: V.870, D.871, N.872, Q.992
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.872
NAG-NAG.19: 5 residues within 4Å:- Chain C: H.129, V.132, E.134, K.173, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 6 residues within 4Å:- Chain B: Y.515
- Chain C: D.313, N.342, T.345, N.594, L.597
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.515
NAG-NAG.21: 2 residues within 4Å:- Chain C: V.651, N.653
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 5 residues within 4Å:- Chain C: T.605, D.606, V.607, N.691, N.692
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:T.605
NAG-NAG.23: 4 residues within 4Å:- Chain C: D.702, N.713, T.715, D.716
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.8: 6 residues within 4Å:- Chain A: V.1201, N.1202
- Chain B: D.869, D.871, N.872, Q.992
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.872
NAG-NAG-BMA.24: 7 residues within 4Å:- Chain A: D.869, V.870, D.871, N.872, Q.992
- Chain C: V.1201, N.1202
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.869, A:N.872
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.25: 3 residues within 4Å:- Chain A: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN.1
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: N.16, T.18, V.19, L.75
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: N.45, N.259
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.179, S.181, T.182
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain A: S.234, N.235, T.236, D.237, N.238
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: F.323, I.419, N.420
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: N.457, T.459, K.523
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: S.549, N.551
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: S.720, P.760, N.762
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.767
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: N.784, I.1142
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: E.911, A.912, N.915
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.45
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: N.179, S.181, T.182
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: S.234, T.236, D.237, N.238
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: F.323, I.419, N.420
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.457
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.551
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: H.671, N.673, Y.734
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: N.762, S.764
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.767
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.784
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: E.911, A.912, N.915
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN.18
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain C: N.16, T.18, V.19, L.75
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.45
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.158
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain C: N.179, S.181, T.182
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain C: S.234, T.236, D.237, N.238
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: F.323, N.420
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.441
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain A: D.84
- Chain C: N.457
Ligand excluded by PLIPNAG.59: 1 residues within 4Å:- Chain C: N.551
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain C: S.720, P.760, N.762
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain C: N.767
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain C: N.784
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain C: E.911, A.912, N.915
Ligand excluded by PLIP- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
01.37: 13 residues within 4Å:- Chain A: N.13, T.17, L.66, K.67, G.68, T.69, Y.71, S.73, W.76, N.230, S.233, N.235, T.236
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:T.17, A:L.66, A:Y.71, A:W.76, A:T.236
- Hydrogen bonds: A:N.13, A:T.17, A:K.67, A:K.67, A:T.69, A:T.69, A:T.69, A:S.233, A:N.235, A:N.235
- Salt bridges: A:K.67
01.49: 16 residues within 4Å:- Chain B: N.13, L.15, T.17, T.18, L.66, K.67, G.68, T.69, Y.71, L.72, S.73, W.76, N.230, A.231, S.233, N.235
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:L.15, B:T.17, B:T.18, B:L.66, B:W.76
- Hydrogen bonds: B:N.13, B:T.17, B:T.17, B:K.67, B:K.67, B:T.69, B:T.69, B:T.69, B:S.233, B:N.235
- Salt bridges: B:K.67
01.64: 15 residues within 4Å:- Chain C: N.13, T.17, L.66, K.67, G.68, T.69, Y.71, S.73, W.76, C.229, N.230, A.231, S.233, N.235, T.236
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:T.17, C:L.66, C:Y.71, C:W.76, C:T.236
- Hydrogen bonds: C:N.13, C:T.17, C:K.67, C:K.67, C:K.67, C:T.69, C:T.69, C:T.69, C:S.233, C:N.235
- Salt bridges: C:K.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C